Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
7271 - 7280 of 8823 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
    2022
    Summary Details
    OPEN
    Title: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
    Author(s): Ka‐Ho Wong, Gregory S. Day, Maarten J. Titulaer, James C. Torner, Merit Cudkowicz, Christopher S. Coffey, Codrin Lungu, Eric C. Klawiter, J. Singleton, Dana Mitchell, Janel Fedler, Dixie Ecklund, David Klements, Michele Costigan, Stacey Clardy
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdf
    Citation Count: 4
  • Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    2022
    Summary Details
    OPEN
    Title: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    Author(s): Jeffrey C. Allen, Eduardo Nobile‐Orazio, Stojan Perić, Hans Katzberg, Stéphanie Cadour, Inge Van de Walle, Iris van Hoomissen, Bert Jacquemyn, Olivier Van de Steen, W. Ludo van der Pol
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdf
    Citation Count: 4
  • Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis
    2022
    Summary Details
    RESTRICTED
    Title: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis
    Author(s): Carol Swetlik, Amy Kunchok, Brittany Lapin, Yadi Li, Vineet Punia
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85
    Citation Count: 0
  • An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
    2022
    Summary Details
    OPEN
    Title: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
    Author(s): Tyler L. Borko, Sean Selva, Ryan D. Baxter, Berenice Cabrera-Martinez, Cody Rester, Stefan Sillau, Daniel M. Pastula, Maite Sabalza, Iswariya Venkataraman, Eagappanath Thiruppathi, Jeffrey L. Bennett, Enrique Alarcón Álvarez, Robert A. Gross, Anna Shah, Ryan Kammeyer, Timothy R. Vollmer, Ross M. Kedl, John R. Corboy, Elena W.Y. Hsieh, Amanda L. Piquet
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0a
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdf
    Citation Count: 1
  • Quality of Life for Patients With Parkinson Disease
    2022
    Summary Details
    RESTRICTED
    Title: Quality of Life for Patients With Parkinson Disease
    Author(s): Lauren Talman
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 98
    Issue #: 22
    Start Page: e2293
    End Page: e2295
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741
    Citation Count: 5
  • Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    2022
    Summary Details
    RESTRICTED
    Title: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    Author(s): Jannik Prasuhn, Martin Göttlich, Britt Ebeling, Sofia Kourou, Friederike Gerkan, Christina Bodemann, Sinja S. Großer, Katharina Reuther, Henrike Hanßen, Norbert Brüggemann
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page: e2683
    End Page: e2692
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288
    Citation Count: 12
  • 2022 Emerging Science Abstracts
    2022
    Summary Details
    RESTRICTED
    Title: 2022 Emerging Science Abstracts
    Author(s):
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 3
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200917
    Citation Count: 1
  • Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy
    2022
    Summary Details
    RESTRICTED
    Title: Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy
    Author(s): Shelley L. Forrest, Maria Carmela Tartaglia, Ain Kim, Paula Alcaide‐Leon, Ekaterina Rogaeva, Anthony E. Lang, Gábor G. Kovács
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page: 1094
    End Page: 1098
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201485
    Citation Count: 16
  • At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer's Disease and Related Research
    2022
    Summary Details
    OPEN
    Title: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer's Disease and Related Research
    Author(s): Jamie Ford, Dimitra Kafetsouli, Heather Wilson, Chinedu Udeh‐Momoh, Marios Politis, Sara Ahmadi‐Abhari, Ilan Rabiner, Lefkos Middleton
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Vol: 9
    Issue #: 1
    Start Page: 67
    End Page: 76
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.14283/jpad.2022.7
    Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdf
    Citation Count: 1
  • Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
    2021
    Summary Details
    RESTRICTED
    Title: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
    Author(s): Silvia Paciotti, Erik Stoops, Cindy François, Giovanni Bellomo, Paolo Eusebi, Hugo Vanderstichele, Davide Chiasserini, Lucilla Parnetti
    Journal Name: Clinical Chemistry and Laboratory Medicine (CCLM)
    Publisher: Walter de Gruyter GmbH
    Vol: 59
    Issue #: 10
    Start Page: 1653
    End Page: 1661
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1515/cclm-2020-1521
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.